Mylan to take Perrigo bid to shareholders on Monday

Perrigo’s management and board have rebuffed the generic-drug maker’s advances since April.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.